![Frank Slack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Slack
Founder at
Impilo Therapeutics, Inc.
Profile
Frank J.
Slack is the founder of Redona Therapeutics, Inc. founded in 2016.
Dr. Slack is also the founder of Impilo Therapeutics, Inc.,MiraDx, Inc. Dr. Slack is currently a Professor at Yale University.
Frank Slack active positions
| Companies | Position | Start |
|---|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2010-07-04 |
Impilo Therapeutics, Inc.
 Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Develops a platform for delivering nucleic acid-based medicines to solid tumor cancers | Founder | - |
Former positions of Frank Slack
| Companies | Position | End |
|---|---|---|
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Founder | - |
MiraDx, Inc.
 MiraDx, Inc. Medical/Nursing ServicesHealth Services Provides research and testing for cancer treatments | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiraDx, Inc.
MiraDx, Inc. Medical/Nursing ServicesHealth Services Provides research and testing for cancer treatments | Health Services |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Health Technology |
Impilo Therapeutics, Inc.
Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Develops a platform for delivering nucleic acid-based medicines to solid tumor cancers | Technology Services |
- Stock Market
- Insiders
- Frank Slack
